IPCA LABORATORIES
|
The Current P/S Ratio of IPCA LABORATORIES is 4.70.
Share Price | ₹1,579.8 | Jan 13,2025 |
Market Cap | ₹40,079.5 Cr | |
Sales-TTM | ₹8,533.4 Cr | TTM-Consolidated Results |
Price/Sales | 4.70x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of IPCA LABORATORIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹40,079.5 Cr] as on Jan 13,2025
(/) Sales [ ₹8,533.4 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 4.70x ]
Thus, for IPCA LABORATORIES , the investors are currently willing to pay '4.70 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of IPCA LABORATORIES !
The chart below summarizes the trend in P/S Ratio of IPCA LABORATORIES over the last five years.
Historical PS (Price/Sales) ratio chart of IPCA LABORATORIES
PS Ratio Performance Analysis for IPCA LABORATORIES
- IPCA LABORATORIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 4.06x.
- IPCA LABORATORIES 's operated at median p/e ratio of 4.1x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, IPCA LABORATORIES 's p/e ratio peaked in Mar2022 at 4.64x.
- IPCA LABORATORIES 's p/e ratio hit its five-year low in Mar2023 of 3.31x.
How does IPCA LABORATORIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
IPCA LABORATORIES | 8,533.4 | 4.70 | 40,079.5 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 50,307.7 | 8.33 | 418,936.0 |
CIPLA LTD | 26,512.0 | 4.38 | 116,200.0 |
DR REDDYS LABORATORIES LTD | 30,084.9 | 3.70 | 111,325.0 |
ZYDUS LIFESCIENCES LTD | 21,483.5 | 4.56 | 98,037.4 |
DIVIS LABORATORIES LTD | 8,614.0 | 17.66 | 152,157.0 |
MANKIND PHARMA LTD | 11,018.0 | 9.70 | 106,880.0 |
TORRENT PHARMACEUTICALS LTD | 11,225.0 | 9.77 | 109,617.0 |
LUPIN LTD | 21,431.3 | 4.59 | 98,275.2 |
AUROBINDO PHARMA LTD | 30,295.0 | 2.23 | 67,480.4 |
ABBOTT INDIA LTD | 6,066.1 | 10.00 | 60,664.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs IPCA LABORATORIES 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.23x |
Max industry PS | 17.66x |
Median industry PS | 4.70x |
Average industry PS | 7.24x |
You may also like the below Video Courses